Harvey Dubiner

A New System, the LipiFlow, for the Treatment of Meibomian Gland Dysfunction

Stephen S. Lane, Harvey Dubiner, Randy J. Epstein et al. · Cornea · 2012 · 273 citations

Medicine, Ophthalmology, Pharmacotherapy +13

Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy

Eli Ipp, David R. Liljenquist, Bruce W. Bode et al. · JAMA Network Open · 2021 · 225 citations · Full text

Health Professions, Autonomous Systems, Ophthalmology +17

Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure

Jason Bacharach, Harvey Dubiner, Brian Levy et al. · Ophthalmology · 2014 · 151 citations

Medicine, Ophthalmology, Pharmacotherapy +14

Artificial Intelligence Detection of Diabetic Retinopathy

Jennifer I. Lim, Carl D. Regillo, Srinivas R. Sadda et al. · Ophthalmology Science · 2022 · 140 citations · Full text

Health Professions, Ophthalmology, Vision Science +17

The efficacy and safety of the Dorzolamide—timolol combination versus the concomitant administration of its components11Ms. Strohmaier and Drs. Snyder and Adamsons are employees of Merck & Co., Inc, the manufacturer of the dorzolamide-timolol combination. Dr. DuBiner has no proprietary interest in the dorzolamide-timolol combination or Merck.

Kim M. Strohmaier, Ellen Snyder, Harvey Dubiner et al. · Ophthalmology · 1998 · 139 citations

Pharmacy, Pharmacology, Pharmacotherapy +5